8/28/2013 7:08:35 AM
What’s in a new name? More than usual for Enteris Biopharma. That’s because the Boonton, NJ-based biotech is what remains of Unigene Laboratories, a three-decade old company best known both for a way to turn injectable peptide drugs into pills, and disappointing Wall Street investors. Unigene is now in the biotech graveyard, having been vanquished by debt and crippling regulatory decisions, and ultimately sold in pieces at a few auctions earlier this year.
Help employers find you! Check out all the jobs and post your resume.
comments powered by